The Federal Trade Commission has filed a lawsuit seeking to block biotechnology company Amgen from buying Horizon Therapeutics for $27.8 billion — the first time the FTC has tried to
The Federal Trade Commission is suing to block Amgen Inc.'s $28 billion acquisition of Horizon Therapeutics to prevent a monopoly in the market for d.rugs that treat critical ailments
US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the